Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2010, Article ID 510834, 5 pages
http://dx.doi.org/10.1155/2010/510834
Research Article

Availability of Antimalarial Drugs and Evaluation of the Attitude and Practices for the Treatment of Uncomplicated Malaria in Bangui, Central African Republic

1Institut Pasteur de Bangui, Avenue Pasteur, BP 923, Central African Republic
2Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, EA3677, France

Received 8 September 2009; Accepted 22 January 2010

Academic Editor: Sukla Biswas

Copyright © 2010 Alexandre Manirakiza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Guidelines for the treatment of malaria,” WHO/HTM/MAL/2006.1108, June 2006, http://whqlibdoc.who.int/publications/2006/9241546948_eng_full.pdf.
  2. A. Niandou, Marché parallèle des médicaments au Niger: exemple de la communauté urbaine de Niamey, Thése de doctorat en pharmacie, Dakar, Senegal, 1993.
  3. P. Olliaro, “Drug resistance hampers our capacity to roll back malaria,” Clinical Infectious Diseases, vol. 41, supplement 4, pp. S247–S257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Robert, K. Macintyre, J. Keating et al., “Malaria transmission in urban sub-Saharan Africa,” American Journal of Tropical Medicine and Hygiene, vol. 68, no. 2, pp. 169–176, 2003. View at Google Scholar · View at Scopus
  5. D. Menard, N. Madji, A. Manirakiza, D. Djalle, M. R. Koula, and A. Talarmin, “Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine- pyrimethamine combination in Central African children with noncomplicated malaria,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 5, pp. 581–585, 2005. View at Google Scholar · View at Scopus
  6. I. Bergeri, D. D. Zoguéreh, N. Madji et al., “In vivo evaluation of chloroquine therapeutic efficacy in uncomplicated Plasmodium falciparum malaria in Central African Republic in 1997 and 1998,” Bulletin de la Societe de Pathologie Exotique, vol. 96, no. 1, pp. 29–34, 2003. View at Google Scholar · View at Scopus
  7. K. Leonard and M. C. Masatu, “Outpatient process quality evaluation and the Hawthorne effect,” Social Science and Medicine, vol. 63, no. 9, pp. 2330–2340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Fassin, “La vente illicite des médicaments au Sénégalet et ses Conséquences pour la santé des populations,” Bulletin of the Exotic Pathology Society, vol. 79, pp. 557–570, 1996. View at Google Scholar
  9. J. M. Trapsida, “Mieux cerner le marché illicite des médicaments en Afrique, pour une lutte plus efficace,” Communication pour la table ronde de ReMeD, Octobre 1999.
  10. O. M. S. Minzi, M. J. Moshi, D. Hipolite et al., “Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania,” Journal of Clinical Pharmacy and Therapeutics, vol. 28, no. 2, pp. 117–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. A. Amin, R. W. Snow, and G. O. Kokwaro, “The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector,” Journal of Clinical Pharmacy and Therapeutics, vol. 30, no. 6, pp. 559–565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Das and J. S. Hammer, Strained Mercy: The Quality of Medical Care in Delhi, Policy Research Working Paper Series, no. 3228, The World Bank, The Institute of Socio-Economic Research on Development and Democracy, Washington, DC, USA, 2004, http://ssrn.com/abstract=610269.
  13. J.-A. Mulligan, R. Mandike, N. Palmer et al., “The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania,” Tropical Medicine and International Health, vol. 11, no. 4, pp. 452–461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. A. Williams, D. Durrheim, and R. Shretta, “The process of changing national malaria treatment policy: lessons from country-level studies,” Health Policy and Planning, vol. 19, no. 6, pp. 356–370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Chandramohan, S. Jaffar, and B. Greenwood, “Use of clinical algorithms for diagnosing malaria,” Tropical Medicine and International Health, vol. 7, no. 1, pp. 45–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Zurovac, B. A. Larson, W. Akhwale, and R. W. Snow, “The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya,” Tropical Medicine and International Health, vol. 11, no. 8, pp. 1185–1194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Jonkman, R. A. Chibwe, C. O. Khoromana et al., “Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi,” Bulletin of the World Health Organization, vol. 73, no. 2, pp. 223–227, 1995. View at Google Scholar · View at Scopus
  18. D. Zurovac, A. K. Rowe, S. A. Ochola et al., “Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya,” International Journal of Epidemiology, vol. 33, no. 5, pp. 1080–1091, 2004. View at Publisher · View at Google Scholar · View at Scopus